RxDoctor Payments Data

Deirdre Clark, NP

Adult Health · Willimantic, CTNPI 1811251713

Payments from drug & device makers

$675in general payments, 2019–2025

Across 29 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$173
  • Novartis$155
  • E.r. Squibb & Sons, L.L.C.$132
  • Actelion Pharmaceuticals US, Inc.$64
  • Boehringer Ingelheim$50
  • Pfizer$25
  • plus $76 from 4 others

What the payments were for

  • Food & beverage$675100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$675 in reported general payments places this provider in the 60th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$30,123
Medicare patients
168
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban264$390,634
XareltoRivaroxaban92$127,291
EntrestoSacubitril/Valsartan43$53,003
Repatha SureclickEvolocumab55$52,780
JardianceEmpagliflozin45$52,248
Praluent PenAlirocumab30$20,215
Metoprolol Succinate417$5,900
Atorvastatin Calcium286$2,903
Diltiazem 24hr Er (Cd)Diltiazem Hcl64$2,549
Ranolazine ErRanolazine16$1,807
Isosorbide Mononitrate ErIsosorbide Mononitrate133$1,775
Potassium Chloride35$1,715
Midodrine Hcl18$1,520
Rosuvastatin Calcium139$1,352
ClopidogrelClopidogrel Bisulfate83$1,137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$390,634264 claims
Johnson & JohnsonXarelto$16$127,29192 claims
NovartisEntresto$155$53,00343 claims
Boehringer IngelheimJardiance$50$52,24845 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 418 adult health providers in Connecticut.

Other adult health in Willimantic

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →